Indications

• Medullary Thyroid Cancer (see xxxx, [[xxxx]]): FDA-approved
• Non-Small Cell Lung Cancer: investigational
• Prostate Cancer: investigational
• Bladder Cancer: investigational
• Ovarian Cancer: investigational
• Melanoma: investigational
• Breast Cancer: investigational
• Pancreatic Cancer: investigational
• Heptaocellular Carcinoma: investigational
• Renal Cancer: investigational

---

Pharmacology

• Small Molecule Inhibitor of c-Met and VEGFR2 Tyrosine Kinases: inhibits tumor growth, metastasis, and angiogenesis

Metabolism

• xxx

---

Administration

• xxx

Dose Adjustment

• Hepatic: xxx
• Renal: xxx

---

Adverse Effects

Other Adverse Effects

• xxx
• xxx
• xxx
• xxx

---

References

• xxx